3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Xeroderma Pigmentosum
1
Uterine Cervical Dysplasia
1
Trichothiodystrophy Syndromes
1
Squamous Intraepithelial Lesions
1
Sexuality
1
Oligodendroglioma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Cockayne Syndrome
1
Carcinoma, Endometrioid
1
Breast Cancer Survivors
1
Bone Neoplasms
1
Atypical Squamous Cells of the Cervix
1
Astrocytoma
1
Interventions
Cyclophosphamide
30
Rituximab
26
Biopsy
23
Specimen Handling
20
Magnetic Resonance Spectroscopy
18
fludarabine
14
Prednisone
13
Vincristine
11
obinutuzumab
10
Lenalidomide
10
Etoposide
10
Doxorubicin
10
Bendamustine Hydrochloride
9
pembrolizumab
7
venetoclax
6
fludarabine phosphate
6
X-Rays
6
Tacrolimus
6
Nuclear Medicine Department, Hospital
6
Dexamethasone
6
Bortezomib
6
trametinib
5
ibrutinib
5
glofitamab
5
acalabrutinib
5
Mycophenolic Acid
5
Gemcitabine
5
Crizotinib
5
Busulfan
5
copanlisib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Restraint, Physical
×
90 days
×
Clear all
No trials found.